NeoGenomics
+$0.27 (+0.62%) Today
$0.00 (0.00%) As of 10:00 PM UTC after-hours
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell NeoGenomics and other ETFs, options, and stocks.
About NEO
NeoGenomics, Inc. is a clinical laboratory company, which engages in cancer genetics diagnostic testing and pharma services. It operates through the Clinical Services and Pharma Services segments.
CEO
Mark Mallon
Employees
1,700
Headquarters
Fort Myers, Florida
Founded
1998
NEO Key Statistics
Market Cap
5.36B
Price-Earnings Ratio
77.77
Dividend Yield
—
Average Volume
1.39M
High Today
$44.09
Low Today
$42.60
Open Price
$43.01
Volume
610.70K
52 Week High
$61.57
52 Week Low
$36.00
Analyst Ratings
92%
of 12 ratings
Buy
91.7%
Hold
8.3%
Sell
0%
NEO Earnings
-$0.10
-$0.02
$0.06
$0.14
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Estimated
— per share
Actual
Available Nov 4, Pre-Market